Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP).

被引：3
|
作者：
Sweeney, Christopher
Xie, Wanling
Regan, Meredith M.
Nakabayashi, Mari
Buyse, Marc E.
Clarke, Noel W.
Collette, Laurence
Dignam, James J.
Fizazi, Karim
Habibian, Muriel
Halabi, Susan
Kantoff, Philip W.
Parulekar, Wendy R.
Sandler, Howard M.
Sartor, Oliver
Soule, Howard R.
Sydes, Matthew Robert
Tombal, Bertrand F.
Williams, Scott G.
机构：
[1] Harvard Canc Ctr, Dana Farber Canc Inst, Boston, MA USA
[2] Harvard Med Sch, Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Dana Farber Canc Inst, Boston, MA 02115 USA
[4] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA
[5] Int Drug Dev Inst, Cambridge, MA USA
[6] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England
[7] EORTC Headquarters, Brussels, Belgium
[8] Univ Chicago, Chicago, IL 60637 USA
[9] Univ Paris Sud, Inst Gustave Roussy, Villejuif, France
[10] UNICANCER, Paris, France
[11] Duke Univ, Med Ctr, Durham, NC USA
[12] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[13] Queens Univ, Canc Res Inst, NCIC Clin Trials Grp, Kingston, ON, Canada
[14] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[15] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA
[16] Prostate Canc Fdn, Santa Monica, CA USA
[17] MRC Clin Trials Unit, London, England
[18] Catholic Univ Louvain, Inst Rech Clin, Brussels, Belgium
[19] Peter MacCallum Canc Ctr, East Melbourne, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5023
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5023
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Metastasis free survival (MFS) is a surrogate for overall survival (OS) in localized prostate cancer (CaP)
    Xie, W.
    Sweeney, C.
    Regan, M.
    Nakabayashi, M.
    Buyse, M.
    Clarke, N.
    Collette, L.
    Dignam, J.
    Fizazi, K.
    Habibian, M.
    Halabi, S.
    Kantoff, P.
    Parulekar, W.
    Sandler, H. M.
    Sartor, O.
    Soule, H.
    Sydes, M.
    Tombal, B.
    Williams, S.
    ANNALS OF ONCOLOGY, 2016, 27
  • [2] Meta-analysis of disease free survival (DFS) as a surrogate for overall survival (OS) in localized renal cell carcinoma (RCC).
    Harshman, Lauren Christine
    Xie, Wanling
    Moreira, Raphael Brandao
    Gustavo, Ruiz
    Sweeney, Christopher
    Choueiri, Toni K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [3] DISEASE-FREE SURVIVAL (DFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN ADULTS WITH RESECTABLE ESOPHAGEAL OR GASTROESOPHAGEAL JUNCTION CANCER: A CORRELATION META-ANALYSIS
    Leung, L.
    Kurt, M.
    Singh, P.
    Kim, I
    Donnellan, G.
    Kanters, S.
    VALUE IN HEALTH, 2021, 24 : S1 - S1
  • [4] DISEASE-FREE SURVIVAL (DFS) AS A SURROGATE ENDPOINT FOR OVERALL SURVIVAL (OS) IN HER2 NEGATIVE (HER2-) PRIMARY BREAST CANCER (BC)
    McCrea, C.
    Chatzidaki, I
    Drane, E.
    McArthur, E.
    Beaver, S.
    Reason, T.
    Gulati, P.
    VALUE IN HEALTH, 2020, 23 : S425 - S425
  • [5] Disease-Free Survival is a Promising Surrogate for Overall Survival in Colorectal Cancer Studies
    Morris, Jeffrey S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (01): : 5 - 6
  • [6] Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
    Xie, Wanling
    Regan, Meredith M.
    Buyse, Marc
    Halabi, Susan
    Kantoff, Philip W.
    Sartor, Oliver
    Soule, Howard
    Clarke, Noel W.
    Collette, Laurence
    Dignam, James J.
    Fizazi, Karim
    Paruleker, Wendy R.
    Sandler, Howard M.
    Sydes, Matthew R.
    Tombal, Bertrand
    Williams, Scott G.
    Sweeney, Christopher J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (27) : 3097 - 3104
  • [7] Can disease-free survival be a surrogate for overall survival for drug approvals?
    Marwick, C
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2004, 96 (03) : 173 - 173
  • [8] Disease-free survival (DFS) as a surrogate for overall survival (OS) in patients (pts) with HR+/HER2-early breast cancer (EBC): A correlation analysis.
    Untch, Michael
    Perol, David
    Mayer, Erica L.
    Cortes, Javier
    Nusch, Arnd
    Cameron, David A.
    Barrios, Carlos
    Delea, Thomas E.
    Salas, Tonatiuh Romero
    Kalra, Manik
    Gupta, Rhea
    Pathak, Purnima
    Fasching, Peter A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Disease-free survival (DFS) as surrogate end-point for overall survival (OS) in early breast cancer (EBC): Correlation may be different according to drugs and/or strategies tested
    Giannarelli, D.
    Bria, E.
    Carlini, P.
    Di Maio, M.
    Cuppone, F.
    Sperduti, I.
    Nistico, C.
    Vaccaro, V.
    Terzoli, E.
    Cognetti, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [10] Re: Metastasis-free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer
    Spahn, Martin
    EUROPEAN UROLOGY, 2018, 73 (01) : 141 - 142
12345